Literature DB >> 24474252

Hypoxia and hypoxia-inducible factor 1 repress SEMA4B expression to promote non-small cell lung cancer invasion.

Hong Jian1, Bin Liu, Jie Zhang.   

Abstract

Sema domain of semaphorin 4B (SEMA4B), which is an interacting protein of LNM35, plays an important role in lung cancer invasion. However, the regulation mechanism of this protein is completely unknown. Here, we report that hypoxia and hypoxia mimic reagent could downregulate the expression of SEMA4B in human non-small cell lung cancer (NSCLC) lines. We provide evidences that SEMA4B is a direct target of hypoxia-inducible factor 1 (HIF-1). Silencing the expression of HIF-1α in cancer cells by RNA interference abolished hypoxia-repressed SEMA4B expression. Using luciferase reporter assay, we showed that HIF-1α recognized a hypoxia-responsive element (HRE) of SEMA4B gene, which is required for HIF-1-repressed SEMA4B expression. Moreover, ectopic expression of SEMA4B abolished invasion of hypoxia-induced NSCLC cells. Taken together, these data would shed novel insights on the mechanisms for invasion of hypoxia-induced NSCLC cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24474252     DOI: 10.1007/s13277-014-1651-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  25 in total

Review 1.  Semaphorins in angiogenesis and tumor progression.

Authors:  Gera Neufeld; Adi D Sabag; Noa Rabinovicz; Ofra Kessler
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 2.  Hypoxia-inducible factors and their roles in energy metabolism.

Authors:  Nobuhito Goda; Mai Kanai
Journal:  Int J Hematol       Date:  2012-04-26       Impact factor: 2.490

3.  CLCP1 interacts with semaphorin 4B and regulates motility of lung cancer cells.

Authors:  H Nagai; N Sugito; H Matsubara; Y Tatematsu; T Hida; Y Sekido; M Nagino; Y Nimura; T Takahashi; H Osada
Journal:  Oncogene       Date:  2007-01-08       Impact factor: 9.867

Review 4.  Hypoxia-inducible factors as key regulators of tumor inflammation.

Authors:  Soulafa Mamlouk; Ben Wielockx
Journal:  Int J Cancer       Date:  2012-11-02       Impact factor: 7.396

5.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

Review 6.  Role of VHL gene mutation in human renal cell carcinoma.

Authors:  Wani Arjumand; Sarwat Sultana
Journal:  Tumour Biol       Date:  2011-11-29

7.  Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells.

Authors:  Tsutomu Imai; Akiko Horiuchi; Cuiju Wang; Kenji Oka; Satoshi Ohira; Toshio Nikaido; Ikuo Konishi
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

Review 8.  HIF-1: an oxygen and metal responsive transcription factor.

Authors:  Patrick Maxwell; Konstantin Salnikow
Journal:  Cancer Biol Ther       Date:  2004-01-10       Impact factor: 4.742

Review 9.  Lung cancer surgery: an up to date.

Authors:  Nikolaos Baltayiannis; Michail Chandrinos; Dimitrios Anagnostopoulos; Paul Zarogoulidis; Kosmas Tsakiridis; Andreas Mpakas; Nikolaos Machairiotis; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Nikolaos Courcoutsakis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2013-09       Impact factor: 2.895

Review 10.  Hypoxia-regulated target genes implicated in tumor metastasis.

Authors:  Ya-Ping Tsai; Kou-Juey Wu
Journal:  J Biomed Sci       Date:  2012-12-14       Impact factor: 8.410

View more
  9 in total

1.  Sevoflurane suppresses hypoxia-induced growth and metastasis of lung cancer cells via inhibiting hypoxia-inducible factor-1α.

Authors:  Hua Liang; Cheng Xiang Yang; Bin Zhang; Han Bing Wang; Hong Zhen Liu; Xiao Hong Lai; Mei Juan Liao; Tao Zhang
Journal:  J Anesth       Date:  2015-05-23       Impact factor: 2.078

2.  MiR-129 regulates MMP9 to control metastasis of non-small cell lung cancer.

Authors:  Jun Li; Haiying Wang; Honggang Ke; Songshi Ni
Journal:  Tumour Biol       Date:  2015-02-26

3.  Semaphorin 4B promotes tumor progression and associates with immune infiltrates in lung adenocarcinoma.

Authors:  Jun Jiang; Yuan Lu; Fang Zhang; Tao Pan; Zhipei Zhang; Yi Wan; Xinling Ren; Rui Zhang
Journal:  BMC Cancer       Date:  2022-06-08       Impact factor: 4.638

4.  SEMA4b inhibits MMP9 to prevent metastasis of non-small cell lung cancer.

Authors:  Hong Jian; Yi Zhao; Bin Liu; Shun Lu
Journal:  Tumour Biol       Date:  2014-08-06

Review 5.  Transmembrane semaphorins: Multimodal signaling cues in development and cancer.

Authors:  Sreeharsha Gurrapu; Luca Tamagnone
Journal:  Cell Adh Migr       Date:  2016-06-13       Impact factor: 3.405

6.  The mechanisms and significance of up-regulation of RhoB expression by hypoxia and glucocorticoid in rat lung and A549 cells.

Authors:  Gao-Xiang Huang; Xiao-Yu Pan; Yi-Duo Jin; Yan Wang; Xiao-Lian Song; Chang-Hui Wang; Yi-Dong Li; Jian Lu
Journal:  J Cell Mol Med       Date:  2016-02-24       Impact factor: 5.310

7.  Combined shRNA over CRISPR/cas9 as a methodology to detect off-target effects and a potential compensatory mechanism.

Authors:  Liat Peretz; Elazar Besser; Renana Hajbi; Natania Casden; Dan Ziv; Nechama Kronenberg; Liat Ben Gigi; Sahar Sweetat; Saleh Khawaled; Rami Aqeilan; Oded Behar
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

8.  Whole-exome sequencing identifies common and rare variant metabolic QTLs in a Middle Eastern population.

Authors:  Noha A Yousri; Khalid A Fakhro; Amal Robay; Juan L Rodriguez-Flores; Robert P Mohney; Hassina Zeriri; Tala Odeh; Sara Abdul Kader; Eman K Aldous; Gaurav Thareja; Manish Kumar; Alya Al-Shakaki; Omar M Chidiac; Yasmin A Mohamoud; Jason G Mezey; Joel A Malek; Ronald G Crystal; Karsten Suhre
Journal:  Nat Commun       Date:  2018-01-23       Impact factor: 14.919

Review 9.  SEMAPHORINS and their receptors: focus on the crosstalk between melanoma and hypoxia.

Authors:  Elisabetta Valentini; Marta Di Martile; Donatella Del Bufalo; Simona D'Aguanno
Journal:  J Exp Clin Cancer Res       Date:  2021-04-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.